Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Casdin Capital
AddedFeb 13, 2024
UpdatedJul 16, 2026
Casdin Capital

Casdin Capital

Operating

Casdin Capital, LLC: A US-based investment firm specializing in life sciences, biotech, and pharma sectors.

Location
New York City, NY, US
Founded
2012
Firm
Compare
Portfolio
Employees
Website

Casdin Capital specializes in life sciences, biotechnology, and pharmaceutical investments. The firm focuses on companies leveraging molecular information and advanced technologies across healthcare, biotech, synthetic biology, and related sectors. Casdin Capital's investment approach is rooted in research, driven by data, and validated by returns.

The firm's portfolio includes notable companies such as 23andMe, Ginkgo Bioworks, and Flatiron Health. Casdin Capital's investments span various stages, with a particular emphasis on Series A to C rounds. The firm's expertise in the life sciences sector and data-driven approach provide valuable support to its portfolio companies, helping them navigate the complex and dynamic healthcare and biotechnology landscapes.

Casdin Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments156
Current Portfolio Count105
Total Portfolio Exits4

Top Investment Stages

Series B48 (37.2%)
Series A33 (25.6%)
Series C26 (20.2%)
Series D11 (8.5%)
Series Unknown11 (8.5%)

Stage Mix

Series B 37%Series A 26%Series C 20%Series D 9%Series Unknown 9%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Flare Therapeutics logo

Flare Therapeutics

Remix Therapeutics logo

Remix Therapeutics

Rome Therapeutics logo

Rome Therapeutics

Thyme Care logo

Thyme Care

Octave Bioscience logo

Octave Bioscience

Septerna logo

Septerna

Orbital Therapeutics logo

Orbital Therapeutics

Function Oncology logo

Function Oncology

Chroma Medicine logo

Chroma Medicine

iVexSol logo

iVexSol

Nest Genomics logo

Nest Genomics

Asimov logo

Asimov

Vector Biomed logo

Vector Biomed

Fog Pharmaceuticals logo

Fog Pharmaceuticals

LetsGetChecked logo

LetsGetChecked

Idrx logo

Idrx

Auron Therapeutics logo

Auron Therapeutics

Character Biosciences logo

Character Biosciences

Invetx logo

Invetx

Moma Therapeutics logo

Moma Therapeutics

Arzeda logo

Arzeda

Celsius Therapeutics logo

Celsius Therapeutics

Deepcell logo

Deepcell

2seventy bio logo

2seventy bio

Molecular Assemblies logo

Molecular Assemblies

Casdin Capital - Similar Investment Firms

Foresite Capital logo

Foresite Capital

Amicus Capital Partners logo

Amicus Capital Partners

Capitan Investment Partners logo

Capitan Investment Partners

Candou Ventures logo

Candou Ventures

Acorn Bioventures logo

Acorn Bioventures

Winklevoss Capital logo

Winklevoss Capital

BioInnovation logo

BioInnovation

CapitalX logo

CapitalX

GoldenArc Capital logo

GoldenArc Capital

goldenarccap.com

Caxton Advantage Life Sciences Fund logo

Caxton Advantage Life Sciences Fund

InFocus Capital Partners logo

InFocus Capital Partners

Illumina Ventures logo

Illumina Ventures

Panorama Capital logo

Panorama Capital

Caffeinated Capital logo

Caffeinated Capital

General Global Capital logo

General Global Capital

Casdin Capital - Classification

Also Known As
  • Casdin Capital, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 5 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified